These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2651053)

  • 1. Dawn phenomenon and Somogyi effect in IDDM.
    Stephenson JM; Schernthaner G
    Diabetes Care; 1989 Apr; 12(4):245-51. PubMed ID: 2651053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocturnal blood glucose control in type I diabetes mellitus.
    Bolli GB; Perriello G; Fanelli CG; De Feo P
    Diabetes Care; 1993 Dec; 16 Suppl 3():71-89. PubMed ID: 8299480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of nocturnal hypoglycemia to daytime glycemia in IDDM.
    Lerman IG; Wolfsdorf JI
    Diabetes Care; 1988 Sep; 11(8):636-42. PubMed ID: 3219969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocturnal hypoglycemia does not commonly result in major morning hyperglycemia in patients with diabetes mellitus.
    Havlin CE; Cryer PE
    Diabetes Care; 1987; 10(2):141-7. PubMed ID: 3582075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of tight intraoperative glycemic control during off-pump coronary artery bypass surgery in diabetic and nondiabetic patients.
    Lecomte P; Foubert L; Coddens J; Dewulf B; Nobels F; Casselman F; Cammu G
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):937-42. PubMed ID: 21640613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The dawn or Somogyi phenomenon? High morning fasting blood sugar values in young type-1 diabetics].
    Holl RW; Heinze E
    Dtsch Med Wochenschr; 1992 Oct; 117(40):1503-7. PubMed ID: 1396135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twice-daily humulin ultralente insulin decreases morning fasting hyperglycemia.
    Johnson NB; Kronz KK; Fineberg NS; Golden MP
    Diabetes Care; 1992 Aug; 15(8):1031-3. PubMed ID: 1505304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of nocturnal hypoglycemia to cause daytime hyperglycemia in patients with IDDM.
    Hirsch IB; Smith LJ; Havlin CE; Shah SD; Clutter WE; Cryer PE
    Diabetes Care; 1990 Feb; 13(2):133-42. PubMed ID: 2190769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morning hyperglycemia in children and adolescents with type 1 diabetes and different modes of therapy: an evaluation of the DPV data pool].
    Wolf J; Kapellen T; Stachow R; von Schütz W; Holl R
    Klin Padiatr; 2012 Nov; 224(7):471-5. PubMed ID: 22915451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of early-morning rise in blood glucose in children with diabetes at camp.
    Duncan BB; Schmidt MI; Ellis GJ; Davis CE; Heiss G
    Diabetes Care; 1988; 11(7):574-8. PubMed ID: 3203574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting hyperglycemia in type I diabetes mellitus.
    Mozersky RP; Bahl VK; Patel H; Patel N; Palushock S; Yamakawa H; Mook W; Basuray R; Velez-Giraldo JR
    J Am Osteopath Assoc; 1993 Jul; 93(7):769-74. PubMed ID: 8365924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of early-morning hyperglycemia in IDDM patients with long-acting zinc insulin.
    Parillo M; Mura A; Iovine C; Rivellese AA; Lavicoli M; Riccardi G
    Diabetes Care; 1992 Feb; 15(2):173-7. PubMed ID: 1547673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified release terbutaline (SKP1052) for hypoglycaemia prevention: a proof-of-concept study in people with type 1 diabetes mellitus.
    Nosek L; Cardot JM; Owens DR; Ibarra P; Bagate K; Vergnault G; Kaiser K; Fischer A; Heise T
    Diabetes Obes Metab; 2012 Dec; 14(12):1137-44. PubMed ID: 22988932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dawn phenomenon: nocturnal blood glucose homeostasis in insulin-dependent diabetes mellitus.
    Perriello G; De Feo P; Bolli GB
    Diabet Med; 1988 Jan; 5(1):13-21. PubMed ID: 2964322
    [No Abstract]   [Full Text] [Related]  

  • 15. The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation.
    Schmidt MI; Hadji-Georgopoulos A; Rendell M; Margolis S; Kowarski A
    Diabetes Care; 1981; 4(6):579-85. PubMed ID: 6751733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of activated glucose counterregulation on insulin requirements in insulin-dependent diabetes mellitus.
    Bolli GB; Perriello G
    Horm Metab Res Suppl; 1990; 24():87-96. PubMed ID: 2272633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of the dawn phenomenon in type 2 diabetes: implications for diabetes therapy.
    Carroll MF; Hardy KJ; Burge MR; Schade DS
    Diabetes Technol Ther; 2002; 4(5):595-605. PubMed ID: 12450440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge Translation to Optimize Adult Inpatient Glycemic Management With Basal Bolus Insulin Therapy and Improve Patient Outcomes.
    Helmle KE; Chacko S; Chan T; Drake A; Edwards AL; Moore GE; Philp LC; Popeski N; Roedler RL; Rogers EJR; Zimmermann GL; McKeen J
    Can J Diabetes; 2018 Oct; 42(5):505-513.e1. PubMed ID: 29555341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting hyperglycemia and associated free-insulin and cortisol changes in Somogyi-like patients.
    Schmidt MI; Hadji-Georgopoulos A; Rendell M; Margolis S; Kowarski D; Kowarski AA
    Diabetes Care; 1979 Dec; 2(6):457-464. PubMed ID: 26922819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of dawn phenomenon without change in insulin clearance in patients with insulin-dependent diabetes mellitus.
    Campbell PJ; Gerich JE
    Diabetes; 1986 Jul; 35(7):749-52. PubMed ID: 3522315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.